How neuroinflammation contributes to neurodegeneration
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron’s environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perturbations in immune function have been demonstrated to exacerbate neurodegeneration and metabolic diseases (Lumeng and Saltiel, 2011; Ransohoff, 2016; Reilly and Saltiel, 2017).”
From Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice (2022) · cites this paper as Ransohoff, 2016
In the citing paper
“This excessive inflammatory response occurs in many neurodegenerative disorders such as Parkinson's (PD) and Alzheimer's diseases (AD) (Ransohoff, 2016),(Perry and Holmes, 2014),(Burguillos et al., 2011),(Abeliovich and Gitler, 2016), as well as in neurological conditions such as ischemic stroke (Lambertsen et al., 2012),(Burguillos et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Ransohoff, 2016
In the citing paper
“Neuroinflammation, a CNS-specific process characterized by proinflammatory cellular and molecular changes to microglia, astrocytes, and the BBB, is considered a core feature of aging and age-related neurological conditions, most notably AD, PD, and ALS (155).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [155]
In the citing paper
“Interestingly, a common feature of PD patients and mouse models is the accumulation of activated microglia and astrocytes, which would promote increased local concentrations of inflammatory mediators and ROS (84).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [84]
In the citing paper
“The notion that neuroinflammatory processes contribute to disease was once provocative, yet recent studies have uncovered multiple mechanisms by which aberrant gliosis causes detrimental neuroinflammation that can influence tau pathology and accelerate neurodegeneration.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [5]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Self-citation
Cited by
Items 201–300 of 1,008
A novel tau‐based rhesus monkey model of Alzheimer's pathogenesis
Beckman, D., Chakrabarty, P., Ott, S., Dao, A., Zhou, E., Janssen, W. G., Donis‐Cox, K., Muller, S., Kordower, J. H., & Morrison, J. H. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12318 · Cited by 106
Alawode, D. O. T., Heslegrave, A. J., Ashton, N. J., Karikari, T. K., Simrén, J., Montoliu‐Gaya, L., Pannee, J., O´Connor, A., Weston, P. S. J., Lantero‐Rodriguez, J., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13332 · Cited by 104
Cx3cr1- deficient microglia exhibit a premature aging transcriptome
Gyoneva, S., Hosur, R., Gosselin, D., Zhang, B., Ouyang, Z., Cotleur, A. C., Peterson, M., Allaire, N., Challa, R., Cullen, P., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900453 · Cited by 103
“They support brain development and adult CNS homeostasis, functions which are often dysregulated in acute or chronic neurological conditions (Xavier et al, 2014; Casano & Peri, 2015; Ransohoff, 2016; Hickman et al, 2018; Thion et al, 2018b).”
Self-citationTET2 Regulates the Neuroinflammatory Response in Microglia
Carrillo-Jimenez, A., Deniz, Ö., Niklison-Chirou, M. V., Ruiz, R., Bezerra-Salomão, K., Stratoulias, V., Amouroux, R., Yip, P. K., Vilalta, A., Cheray, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.013 · Cited by 104
Obrador, E., Palmer, R. S., López‐Blanch, R., Jihad-Jebbar, A., Vallés, S. L., & Estrela, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126352 · Cited by 113
“If the microglia cells cannot resolve or eliminate a toxic insult in the CNS, they remain reactive and continue to recruit astrocytes and oligodendrocytes, causing an ongoing inflammatory process [54].”
BackgroundGut bacterial composition in a mouse model of Parkinson’s disease
Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Naqib, A., Forsyth, C. B., Green, S. J., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0202 · Cited by 102
“Several studies have demonstrated that neuroinflammation and oxidative stress are the key factors responsible for alpha-synuclein misfolding and aggregation (Deleidi and Gasser, 2013; Dias et al., 2013; Glass et al., 2010; Luna and Luk, 2015; Ransohoff, 2016).”
Eidson, L. N., Kannarkat, G. T., Barnum, C. J., Chang, J., Chung, J., Caspell-Garcia, C., Taylor, P., Mollenhauer, B., Schlossmacher, M. G., Ereshefsky, L., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0935-1 · Cited by 102
“matory markers in the blood and CSF of individuals suffering from neurodegenerative diseases like PD [1], results are discordant [28].”
BackgroundResultMapping microglia and astrocyte activation in vivo using diffusion MRI
Garcia-Hernandez, R., Cerdán Cerdá, A., Trouve Carpena, A., Drakesmith, M., Koller, K., Jones, D. K., Canals, S., & De Santis, S. (2022) · Science Advances · doi:10.1126/sciadv.abq2923 · Cited by 102
Border-associated macrophages in the central nervous system
Sun, R., & Jiang, H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03059-x · Cited by 135
“Neuroinflammation is recognized as a key mediator of lesion formation in the CNS during both the acute and chronic phases of MS [68, 145, 148].”
BackgroundMicroglia-targeting nanotherapeutics for neurodegenerative diseases
Zhao, N., Francis, N. L., Calvelli, H. R., & Moghe, P. V. (2020) · APL Bioengineering · doi:10.1063/5.0013178 · Cited by 104
Chen, Y., Yan, Q., & Sun, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.711710 · Cited by 112
“However, there is still lack of effective treatment strategies against aging-related neurodegenerative diseases, which irreversibly progress and are related to much socioeconomic and personal costs (Ransohoff, 2016).”
BackgroundThe ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy
Beamer, E., Fischer, W., & Engel, T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00021 · Cited by 100
“Brain inflammation, implicated in a host of neurological disorders (Ransohoff, 2016), has been shown to drive increases in BBB permeability (Rochfort and Cummins, 2015), facilitate glutamatergic neurotransmission (Vezzani and Viviani, 2015), initiate pro-apoptotic signaling pathways, promote…”
BackgroundAstrocytic ceramide as possible indicator of neuroinflammation
de Wit, N. M., den Hoedt, S., Martinez-Martinez, P., Rozemuller, A. J., Mulder, M. T., & de Vries, H. E. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1436-1 · Cited by 99
Role of Atypical Chemokine Receptors in Microglial Activation and Polarization
Salvi, V., Sozio, F., Sozzani, S., & Del Prete, A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00148 · Cited by 99
“Transcriptomic and proteomic analysis will help to define the heterogeneity of microglial phenotype associated to different pathological contexts (Ransohoff, 2016b).”
Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases
Liu, B., Ruan, J., Chen, M., Li, Z., Manjengwa, G. M., Schlüter, D., Song, W., & Wang, X. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01233-8 · Cited by 109
The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A
Fu, J., Huang, Y., Bao, T., Liu, C., Liu, X., & Chen, X. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02446-6 · Cited by 107
“Neuroinflammation is characterized by elevated levels of inflammatory mediators or cytokines in the central nervous system (CNS) parenchyma [2].”
BackgroundNew Insights into Microglia–Neuron Interactions: A Neuron’s Perspective
Pósfai, B., Cserép, C., Orsolits, B., & Dénes, Á. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.046 · Cited by 98
Toader, C., Tătaru, C. P., Munteanu, O., Șerban, M., Covache-Busuioc, R.-A., Ciurea, A. V., & Enyedi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312613 · Cited by 122
TREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment
Jay, T. R., von Saucken, V. E., Muñoz, B., Codocedo, J. F., Atwood, B. K., Lamb, B. T., & Landreth, G. E. (2019) · Glia · doi:10.1002/glia.23664 · Cited by 97
“and progression (Efthymiou & Goate, 2017; Karch & Goate, 2015; Ransohoff, 2016), with the identification of TREM2 variants associated with high risk for developing Alzheimer’s disease (AD) (Guerreiro et al.”
BackgroundCalzaferri, F., Ruiz‐Ruiz, C., de Diego, A. M. G., de Pascual, R., Méndez‐López, I., Cano‐Abad, M. F., Maneu, V., de los Ríos, C., Gandía, L., & García, A. G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21710 · Cited by 97
“levels of inflammatory mediators present in the parenchyma of the brain or spinal cord in patients with NNDs; in the long term, this low inflammatory status leads to synaptic dysfunction, loss of synapses, and neuronal death.(142)”
BackgroundOlvera-Rosales, L. B., Cruz-Guerrero, A. E., Ramírez‐Moreno, E., Lira, A. Q., Contreras‐López, E., Ordaz, J. J., Ovando, A. C., Añorve‐Morga, J., Calderón‐Ramos, Z. G., Arias‐Rico, J., et al. (2021) · Foods · doi:10.3390/foods10061261 · Cited by 128
Neuroinflammation in Post-Traumatic Stress Disorder
Lee, D.-H., Lee, J.-Y., Hong, D.-Y., Lee, E.-C., Park, S.-W., Lee, M. R., & Oh, J. S. (2022) · Biomedicines · doi:10.3390/biomedicines10050953 · Cited by 117
Li, S., Cai, Y., Guan, T., Zhang, Y., Huang, K., Zhang, Z., Cao, W., & Guan, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2374608 · Cited by 113
Blood‐brain barrier development: Systems modeling and predictive toxicology
Saili, K. S., Zurlinden, T. J., Schwab, A. J., Silvin, A., Baker, N. C., Hunter, E. S., Ginhoux, F., & Knudsen, T. B. (2017) · Birth Defects Research · doi:10.1002/bdr2.1180 · Cited by 95
“Because microglia can express a range of these features at any given time, one must be cautious to avoid oversimplifying their activation states using obsolete, dichotomous terminology (e.g., M1 versus M2) (Ginhoux et al., 2016; Martinez & Gordon, 2014; Ransohoff, 2016).”
BackgroundReview of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases
Zhang, Y., Anoopkumar‐Dukie, S., Arora, D. S., & Davey, A. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172847 · Cited by 99
The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson’s disease
Zhao, M., Wang, B., Zhang, C., Su, Z., Guo, B., Zhao, Y., & Zheng, R. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00767-2 · Cited by 103
Glial Cells as Therapeutic Approaches in Brain Ischemia-Reperfusion Injury
Hernández, I. H., Villa-González, M., Martín-López, G., Soto, M., & Pérez-Álvarez, M. J. (2021) · Cells · doi:10.3390/cells10071639 · Cited by 104
Immune dynamics in the CNS and its barriers during homeostasis and disease*
Buckley, M. W., & McGavern, D. B. (2022) · Immunological Reviews · doi:10.1111/imr.13066 · Cited by 96
Savage, J. C., Picard, K., González-Ibáñez, F., & Tremblay, M.-È. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00803 · Cited by 94
“Originally believed to mediate inflammatory responses to infection (1), trauma (2), ischemia (3), or neurodegenerative disease (4), recent studies identified microglia as crucial actors in the proper development and maintenance of neuronal circuits (5).”
BackgroundYari, H., Mikhailova, M. V., Mardasi, M., Jafarzadehgharehziaaddin, M., Shahrokh, S., Thangavelu, L. P., Ahmadi, H., Shomali, N., Yaghoubi, Y., Zamani, M., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03122-5 · Cited by 105
“However, it seems that neuroinflammation plays a critical role in their pathogenesis because of the presence of inflammatory mediators at high levels in the brain tissue of rodents with neurodegeneration [6, 7].”
BackgroundXin, Y., Tian, M., Deng, S., Li, J., Yang, M., Gao, J., Pei, X., Wang, Y., Tan, J., Zhao, F., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03148-z · Cited by 91
Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease
Taylor, J. M., Moore, Z., Minter, M. R., & Crack, P. J. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1745-4 · Cited by 97
Beckers, L., Ory, D., Geric, I., Declercq, L., Koole, M. J. B., Kassiou, M., Bormans, G. M., & Baes, M. I. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1099-1 · Cited by 114
“During pathology, activated microglia can promote not only tissue injury (denoted as an M1 phenotype) but also tissue repair and remodeling (denoted as an M2 phenotype), dependent on the type of disease and stage of disease progression [12, 13].”
BackgroundFilamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex
Wang, P., & Ye, Y. (2021) · Nature Communications · doi:10.1038/s41467-020-20322-w · Cited by 93
Henriques, J. F., Serra, D., Dinis, T. C. P., & Almeida, L. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228653 · Cited by 99
“All brain diseases encompass the impairment of biological processes, such as immune and antioxidant responses [20,21].”
BackgroundOf microbes and minds: A narrative review on the second brain aging
Calvani, R., Picca, A., Lo Monaco, M. R., Landi, F., Bernabei, R., & Marzetti, E. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00053 · Cited by 92
“As already outlined for AD, in neurodegenerative diseases, including PD, the passage of bacterial products from the intestine to the circulation and into brain, or “molecular mimicry” processes induced by bacterial amyloids may trigger a persistent neuroinflammation (28, 141, 142) that in turn contributes to neuronal…”
BackgroundFeng, S.-T., Wang, Z.-Z., Yuan, Y.-H., Sun, H.-M., Chen, N.-H., & Zhang, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104336 · Cited by 96
Qiao, C.-M., Sun, M., Jia, X.-B., Yang, L., Zhang, B.-P., Zhao, L., Shi, Y. W., Zhou, Z.-L., Zhu, Y., Cui, C., et al. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03074-3 · Cited by 99
The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction
Mijailović, N. R., Vesić, K., & Borovčanin, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.828476 · Cited by 116
“The inflammatory responses also lead to neuronal death and blockade of neurogenesis, which in turn leads to cognitive impairment (116, 117).”
BackgroundGullotta, G. S., Costantino, G., Sortino, M. A., & Spampinato, S. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119144 · Cited by 110
Acute microglia ablation induces neurodegeneration in the somatosensory system
Rubino, S. J., Mayo, L., Wimmer, I., Siedler, V., Brunner, F., Hametner, S., Madi, A., Lanser, A., Moreira, T., Donnelly, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05929-4 · Cited by 91
Glial Control of Synapse Number in Healthy and Diseased Brain
Lee, E., & Chung, W.-S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00042 · Cited by 91
“These astrocytes exhibit reduced expression of glutamine synthetase and glutamate transporter-1 (GLT-1; Robinson, 2001; Zumkehr et al., 2015), directly inducing aberrant neuronal excitability and synaptic function, which can lead to synapse loss.”
Trettel, F., Di Castro, M. A., & Limatola, C. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.035 · Cited by 89
Schilling, S., Chausse, B., Dikmen, H. O., Almouhanna, F., Hollnagel, J.-O., Lewen, A., & Kann, O. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.05.013 · Cited by 90
Grotemeyer, A., McFleder, R. L., Wu, J., Wischhusen, J., & Ip, C. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878771 · Cited by 90
Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind, K., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109108 · Cited by 89
“Although increased TREM2 may be protective in AD patients (Ewers et al , 2019), in other neurodegenerative diseases, microglia may be overactivated and become dysfunctional (Heneka et al , 2013; Hong et al , 2016a; Ransohoff, 2016).”
Castro‐Sánchez, S., García‐Yagüe, Á. J., López‐Royo, T., Casarejos, M., Lanciego, J. L., & Lastres‐Becker, I. (2018) · Glia · doi:10.1002/glia.23338 · Cited by 89
“It binds to its receptor CX3CR1 located in the microglia at the CNS, acting as a bridge of connection between neurons and microglia (Bisht et al., 2016; Ransohoff, 2016).”
BackgroundRole of Dietary Supplements in the Management of Parkinson’s Disease
Ciulla, M., Marinelli, L., Cacciatore, I., & Stefano, A. D. (2019) · Biomolecules · doi:10.3390/biom9070271 · Cited by 106
“The inflammation depends also on the impaired energy metabolism at the level of th mitochondria, which causes the activation of the microglia and the relative production of a plethora of pro-inflammatory mediators, including prostaglandins, cytokines, chemokines, complement, proteinases, reactive species of oxygen (RO…”
BackgroundTAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
Tondo, G., Perani, D., & Comi, C. (2019) · Disease Markers · doi:10.1155/2019/2387614 · Cited by 88
“Chronic neuroinflammation, mediated by microglia and astrocytes, is a crucial player in neurodegeneration [122].”
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease
Lashgari, N., Roudsari, N. M., Momtaz, S., Sathyapalan, T., Abdolghaffari, A. H., & Sahebkar, A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577758 · Cited by 97
Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury
Lukáčová, N., Kisucká, A., Bimbová, K., Bačová, M., Ileninová, M., Kuruc, T., & Gálik, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413577 · Cited by 96
“M2c subtype is also involved in inflammation dampening and healing and is activated by a potent antiinflammatory cytokine IL-10 and glucocorticoids, resulting in high transforming growth factor beta (TGF-β) expression [39,40].”
BackgroundSterile Neuroinflammation and Strategies for Therapeutic Intervention
Banjara, M., & Ghosh, C. (2017) · International Journal of Inflammation · doi:10.1155/2017/8385961 · Cited by 86
“A recent review article by Ransohoff in science suggested the higher levels of inflammatory mediators in parenchyma of stroke and TBI compared to AD, PD, andALS, indicating potential roles of environmental triggers in the latter group [6].”
Drug development for Alzheimer’s disease: Review
Lao, K., Ji, N., Zhang, X., Qiao, W., Tang, Z., & Gou, X. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2018.1474361 · Cited by 86
“The inflammatory response, which is driven by activated microglia, increases over time as the disease progresses [83].”
BackgroundWang, Y.-W., Zhou, Q., Zhang, X., Qian, Q.-Q., Xu, J.-W., Ni, P.-F., & Qian, Y.-N. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1002-7 · Cited by 86
“a key role in the progression of diverse neurodegenerative diseases, such as Alzheimer’s disease (AD), Huntington’s disease (HD), and Parkinson’s disease (PD), by causing an over-production of proinflammatory cytokines [1, 2].”
BackgroundTREM2‐dependent effects on microglia in Alzheimer's disease
Zhou, Y., Ulland, T. K., & Colonna, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00202 · Cited by 82
“Abnormal protein aggregates in the AD brain are also associated with a glial response, which includes activation and recruitment of microglia and astrocytes to amyloid plaques (Sastre et al., 2006; Ransohoff, 2016).”
BackgroundApolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework
Mentis, A.-F. A., Dardiotis, E., & Chrousos, G. P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0731-7 · Cited by 85
Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice
Sahu, B., Mackos, A. R., Floden, A. M., Wold, L. E., & Combs, C. K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200919 · Cited by 94
miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review
Maciak, K., Dziedzic, A., Miller, E. D., & Saluk, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094332 · Cited by 96
The multifaceted role of platelets in mediating brain function
Burnouf, T., & Walker, T. L. (2022) · Blood · doi:10.1182/blood.2022015970 · Cited by 86
Air Pollution–Related Neurotoxicity Across the Life Span
Cory‐Slechta, D. A., Merrill, A. K., & Sobolewski, M. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-020812 · Cited by 104
Zhang, M., Chen, H., Zhang, W., Liu, Y., Ding, L., Gong, J., Ma, R., Zheng, S., & Zhang, Y. (2023) · Advanced Science · doi:10.1002/advs.202300180 · Cited by 96
Yang, Z., Huang, S., Zhong, K., Huang, W., Huang, Z.-H., He, T., Yang, M.-T., Wusiman, M., Zhou, D.-D., Chen, S., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103026 · Cited by 96
“These cytokines result in neuronal damage and potentially lead to brain injury [59,60].”
BackgroundKerdiles, O., Layé, S., & Calon, F. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.09.003 · Cited by 95
Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases
Sandhu, J. K., & Kulka, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031093 · Cited by 92
“, β-amyloid and α-synuclein), signals produced by injured neurons, or imbalances between pro- and anti-inflammatory processes [6,7].”
BackgroundWang, C., Yang, T., Liang, M., Xie, J., & Song, N. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00265-y · Cited by 91
Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases
Dhahri, M., Alghrably, M., Mohammed, H. A., Badshah, S. L., Noreen, N., Mouffouk, F., Rayyan, S., Qureshi, K. A., Mahmood, D., Lachowicz, J. I., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010001 · Cited by 87
“The role of neuroinflammation in neurodegeneration has been widly described [90,91].”
BackgroundBlood–brain barrier endothelial cells in neurodegenerative diseases: Signals from the “barrier”
Yuan, Y., Sun, J., Dong, Q., & Cui, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1047778 · Cited by 93
“Neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), are defined as disorders characterized by progressive nervous system dysfunction (Ransohoff, 2016).”
BackgroundMcAllister, L. A., Butler, C. R., Mente, S., O’Neil, S. V., Fonseca, K. R., Piro, J. R., Cianfrogna, J. A., Foley, T. L., Gilbert, A. M., Harris, A. R., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00070 · Cited by 91
Wang, H., Li, Y., Ryder, J. W., Hole, J. T., Ebert, P. J., Airey, D. C., Qian, H.-R., Logsdon, B., Fisher, A., Ahmed, Z., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0296-y · Cited by 83
Luchena, C., Zuazo-Ibarra, J., Alberdi, E., Matute, C., & Capetillo-Zarate, E. (2018) · Mediators of Inflammation · doi:10.1155/2018/2530414 · Cited by 82
Neuroinflammation, Microglia, and Cell-Association during Prion Disease
Carroll, J. A., & Chesebro, B. (2019) · Viruses · doi:10.3390/v11010065 · Cited by 82
Early effects of LPS-induced neuroinflammation on the rat hippocampal glycolytic pathway
Vizuete, A. F. K., Fróes, F. T., Seady, M., Zanotto, C., Bobermin, L. D., Roginski, A. C., Wajner, M., Quincozes‐Santos, A., & Gonçalves, C. A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02612-w · Cited by 96
Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous System
Gauberti, M., Fournier, A. P., Docagne, F., Vivien, D., & de Lizarrondo, S. M. (2018) · Theranostics · doi:10.7150/thno.22662 · Cited by 97
“Yet, abnormal activation of the immune system in the brain can lead to autoimmune disorders [3] and worsen brain damages during injuries of the CNS [4, 5].”
BackgroundWang, Y., Li, L., Wu, Y., Zhang, S., Ju, Q., Yang, Y., Jin, Y., Shi, H., & Sun, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106133 · Cited by 84
Luo, M., Lee, L. K. C., Peng, B., Choi, C. H. J., Tong, W. Y., & Voelcker, N. H. (2022) · Advanced Science · doi:10.1002/advs.202201740 · Cited by 92
Mack, J. M., Schamne, M. G., Sampaio, T. B., Pértile, R. A. N., Fernandes, P. A. C. M., Markus, R. P., & Prediger, R. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3472032 · Cited by 90
“Neuroinflammatory mechanisms involved in PD pathogenesis comprise microglial activation, astrogliosis, and lymphocytic infiltration and also involve alterations in the morphology of glial cells, including both astrocytes andmicroglia, indicating their interactions with the alterations in the homeostasis of the environ…”
BackgroundEarly Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Lemche, E. (2018) · Current Genomics · doi:10.2174/1389202919666171229145156 · Cited by 85
Zhou, N., Liu, K., Sun, Y., Cao, Y., & Yang, J. (2019) · Protein & Cell · doi:10.1007/s13238-018-0599-3 · Cited by 81
“Furthermore, it has been increasingly appreciated that microglia have the key involvement in neurodegenerative diseases (Perry et al., 2010; Perry and Holmes, 2014; Zuchero and Barres, 2015; Ransohoff, 2016; Colonna and Butovsky, 2017; Wolf et al., 2017).”
BackgroundHuang, L., Wang, S., Ma, F., Zhang, Y., Peng, Y., Xing, C., Feng, Y., Wang, X., & Peng, Y. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.007 · Cited by 88
Mouse models of neurodegeneration: Know your question, know your mouse
Fisher, E. M. C., & Bannerman, D. M. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq1818 · Cited by 78
“Central nervous system (CNS) inflammation has long been established as important in the progression of neurodegenerative disorders (137).”
BackgroundLi, Q., Wang, Y., Mai, Y., Li, H., Wang, Z., Xu, J., & He, X. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07418 · Cited by 81
The role of T cells in the pathogenesis of Parkinson’s disease
Chen, Z., Chen, S., & Liu, J. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.08.002 · Cited by 86
“Recently, neuroinflammation has attracted the attention of both basic scientists and clinical practitioners due to its potential in developing disease biomarkers and novel therapies (Ransohoff, 2016; Simon et al., 2017; Swanson et al., 2018; Vogelaar et al., 2018).”
Shen, Z., Bao, X., & Wang, R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00314 · Cited by 77
Maeda, J., Minamihisamatsu, T., Shimojo, M., Zhou, X., Ono, M., Matsuba, Y., Ji, B., Ishii, H., Ogawa, M., Akatsu, H., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab011 · Cited by 79
“Since prominent gliosis was involved in AD pathogenesis as a result of neuroinflammatory response (Minter et al. , 2016; Ransohoff, 2016), increases of TSPO and GFAP levels apparently exhibit reactive gliosis for a plaque formation.”
Extracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy
Ruan, J., Miao, X., Schlüter, D., Li, L., & Wang, X. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.020 · Cited by 94
Yin, L., Dai, Q., Jiang, P., Zhu, L. D., Dai, H., Yao, Z., Liu, H., Ma, X., Qu, L., & Jiang, J. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.04.001 · Cited by 87
Long Non-Coding RNAs in Multifactorial Diseases: Another Layer of Complexity
Cipolla, G. A., de Oliveira, J. C., Salviano‐Silva, A., Lobo‐Alves, S. C., Lemos, D. S., Oliveira, L., Jucoski, T. S., Mathias, C., Pedroso, G. A., Zambalde, É. P., et al. (2018) · Non-Coding RNA · doi:10.3390/ncrna4020013 · Cited by 84
“In addition to the role of many genes involved in regulation, production, and degradation of these malfunctioning proteins inside the neurons, part of the neurodegeneration is caused by the involvement of other cells and inflammation components [154].”
BackgroundPhysical Exercise-Induced Myokines in Neurodegenerative Diseases
Lee, B., Shin, M., Park, Y., Won, S.-Y., & Cho, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115795 · Cited by 79
“However, chronically activated neuroinflammation in the nervous system of ND patients plays a causal role in the pathogenesis of ND [302,303].”
BackgroundZhong, J., Qiu, X., Yu, Q., Chen, H., & Yan, C. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.266 · Cited by 84
Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
Matejuk, A., Vandenbark, A. A., & Offner, H. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.672455 · Cited by 78
“In neurodegenerative diseases, large-scale genomewide association studies (GWAS) show more than 20 loci in immune-related genes mostly expressed in microglia or myeloid cells (15).”
BackgroundKaduševičius, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126637 · Cited by 58
Amyloid beta acts synergistically as a pro-inflammatory cytokine
LaRocca, T. J., Cavalier, A. N., Roberts, C. M., Lemieux, M. R., Ramesh, P., Garcia, M. A., & Link, C. D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105493 · Cited by 78
“Neuroinflammation is characterized by increased production of pro-inflammatory cytokines in the CNS, especially by microglia and astroglia [7, 8].”
BackgroundXu, H., Wang, Y., Song, N., Wang, J., Jiang, H., & Xie, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00455 · Cited by 79
“Although the etiology of PD is not yet elucidated, increasing evidence implicates that microglia-mediated inflammatory processes contribute to the degeneration of DA neurons in PD (Ransohoff, 2016).”
BackgroundBurns, J. C., Cotleur, B., Walther, D. M., Bajrami, B., Rubino, S. J., Wei, R., Franchimont, N., Cotman, S. L., Ransohoff, R. M., & Mingueneau, M. (2020) · eLife · doi:10.7554/elife.57495 · Cited by 78
Self-citationSFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation
Rueda‐Carrasco, J., Martín‐Bermejo, M. J., Pereyra, G., Mateo, M. I., Borroto, A., Brosseron, F., Kummer, M. P., Schwartz, S., López‐Atalaya, J. P., Alarcón, B., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051696 · Cited by 82
“…dysfunction, either as a consequence of hyper-or hypofunctionality, can also be the cause of neuronal damage, rather than its consequence, strongly contributing to the progression of neurodegenerative diseases (Ransohoff, 2016; Sarlus & Heneka, 2017; Hickman et al , 2018; Escartin et al , 2019).”
Zhao, Y., Chen, X., Wu, Y., Wang, Y., Li, Y., & Xiang, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00140 · Cited by 83
“It is well established that Aβ plaques sustain the activation of microglia, resulting in constant production of inflammatory cytokines and reactive oxygen species, which lead to neurodegeneration (Pimplikar, 2014; Ransohoff, 2016).”
BackgroundSekar, P., Huang, D.-Y., Hsieh, S.-L. E., Chang, S., & Lin, W. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0293-3 · Cited by 86
Microbiota and neurodegenerative diseases
Marizzoni, M., Provasi, S., Cattaneo, A., & Frisoni, G. B. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000496 · Cited by 76
Castro-Sánchez, S., García-Yagüe, Á. J., Kügler, S., & Lastres-Becker, I. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101118 · Cited by 76
“Besides neuronal degeneration, it is also known that the neuron environment contributes to this event, where glial cells play a crucial role [2].”
BackgroundWelcome, M. O. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08547-5 · Cited by 80
“2016; Ransohoff 2016).”
Metadata
- Authors
- Ransohoff, R. M.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Ransohoff, Richard M.
- Venue
- Science
- Published
- 2016-08-19
- Volume
- 353
- Issue
- 6301
- Pages
- 777-783
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2517534055
- Semantic Scholar
- bfcfccbbc79f79cab04ba4617a0680c58ddb26a2
- Cited by
- 1,967
- References
- 87
- Citations by year
- 2026: 178 · 2025: 182 · 2024: 191 · 2023: 197 · 2022: 241 · 2021: 262 · 2020: 213 · 2019: 192 · 2018: 166 · 2017: 130 · 2016: 11
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neuroinflammation, neurodegeneration, glial cells, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal lobar dementia
- MeSH terms
- CX3C Chemokine Receptor 1, Blood-Brain Barrier, Humans, Inflammation, Membrane Glycoproteins, Neurons, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.